Outsourced Pharma App Notes & Case Studies
-
Extractables In Single-Use Systems Used In ADC Manufacturing
9/23/2024
To address concerns about using organic solvents in the ADC process, extractables studies were conducted on a disposable chromatography column housing and two different disposable flow paths.
-
CDMO Accelerates Contract Manufacturing With Electronic Batch Records
9/18/2024
A prominent CDMO sought a specialized software solution to streamline and accelerate its manufacturing processes, enabling the efficient production of complex, customized products in record time.
-
Impact Of Media Selection
6/30/2025
To highlight the importance of media selection, a study was conducted assessing the effect of three commercially available cGMP grade medias and their influence on T-cell phenotype.
-
Tackling Antimicrobial Resistance
5/14/2024
Learn how three companies collaborated to develop a new antibiotic to address the increasing development of antimicrobial resistance (AMR) that threatens the global health landscape.
-
Simplifying CHO Cell Line Genetic Stability Testing
4/11/2024
Here, we describe the use of whole genome sequencing to perform a comprehensive assessment of genetic stability in clonally derived CHO cell banks using the Aptegra™ CHO genetic stability assay.
-
A Smarter Workforce Strategy
8/11/2025
Discover compliant, on-site scientific staffing that ensures continuity, reduces HR burden, avoids co-employment risks, and outperforms temporary staffing in retention, cost savings, and operational efficiency.
-
Modifying The Micro-Environment To Improve Dissolution Rate
6/11/2025
Discover how modifying the micro-environment with targeted excipients can significantly enhance the dissolution rate of poorly soluble drugs using conventional manufacturing methods.
-
Creating Equity
7/10/2025
Eurofins PSS provided full-time, benefit-rich staffing to replace inequitable temporary roles, creating long-term value, equity, and continuity for a major biopharma client.
-
Optimizing Upstream Process Development To Increase mAb Titers
3/28/2025
Uncover how we were able to help a client develop an efficient upstream process for a novel monoclonal antibody (mAb), resulting in a more than 100% increase in titers.
-
Cancer Therapeutic Drug Developer Minimizes Production Losses
1/8/2024
Follow the journey of a prominent cancer therapeutics developer who faced persistent manufacturing challenges with liquid-filled capsules, and how they overcame product and monetary losses.